Last reviewed · How we verify
NCT06210997
Factors Determining Time Allocation of a MCQ Examination
trial testing Questionaires in Factors Determining Time Allocation of a Multiple-Choice Question Examination in 298 participants. Completed in 1 July 2023.
1 June 2022
Quick facts
| Lead sponsor | Suranaree University of Technology |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 298 |
| Start date | 1 May 2021 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 July 2023 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Questionaires
Conditions studied
- Factors Determining Time Allocation of a Multiple-Choice Question Examination — all drugs for Factors Determining Time Allocation of a Multiple-Choice Question Examination →
Sponsor
Suranaree University of Technology
Who can join
Eligibility, any sex, with Factors Determining Time Allocation of a Multiple-Choice Question Examination. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The MCQ is one of the objective assessment methods. It is proper to evaluate the cognitive domain of learners with high objectivity. However, there are no definite criteria for determining the appropriate exam time. The ability to comprehend the meaning of a text, when reading, cannot be directly applied to reading for decision-making or answering questions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The equation for medical multiple-choice question testing time estimation.
Kreepala C, Keeratibharat N, Aekgawong S, Wattanavaekin K, et al · · 2024 · PMID 38694350 · DOI 10.1097/ms9.0000000000002010
Verify or expand the search:
- PubMed search for NCT06210997
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionaires
Trials testing the same drug.
- NCT06720532 — Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177 · recruiting
- NCT04430686 — Respiratory Complications in ALS · completed
- NCT03550586 — Long Term Outcomes Following a Post Dural Puncture Headache · completed
- NCT03122327 — cGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study. · unknown
- NCT04094753 — Think Dry: Optimalisation of Diagnostic Process of Urinary Incontinence in Older People · unknown
Other Suranaree University of Technology trials
Trials by the same sponsor.
- NCT07137351 — The Biosensor Using the Target Urine VOCs for Detecting DKD Diabetic Kidney Disease · withdrawn
- NCT07165821 — Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients · NA · completed
- NCT06211010 — The Target Urine VOCs Biosensor for Genitourinary Malignancy Detection · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06210997 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Suranaree University of Technology
- Last refreshed: 18 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06210997.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing